VG Life Sciences Inc. (VGLS)

0,0001 0,0000 (0,00%) Börsenschluss: 02:44PM EDT

VG Life Sciences Inc.

121 Gray Avenue
Suite 200
Santa Barbara, CA 93101
United States
805 879 9000
https://www.vglifesciences.com

Sektor(en): Real Estate
Branche: Real Estate - Development
Vollzeitmitarbeiter: 1

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Haig Keledjian	Co-Founder, Chairman, CEO, President, VP of Research & Development, CFO and Secretary	292,5k	N/A	1962
Dr. M. Karen Newell-Rogers	Chief Scientist	N/A	N/A	N/A
Robert A. Forrester	Corporate Counsel	N/A	N/A	N/A
Mr. Robert Berliner B.Sc., J.D.	Consultant & Advisory Board Member	N/A	N/A	N/A

Die Beträge haben den Stand 31. Dezember 2005 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

VG Life Sciences Inc., a biotechnology company, researches and develops a pipeline of transformative therapies for combat cancer, infectious diseases, and autoimmune diseases caused by chronic inflammation. It offers VG1177, a solution that deploys a synthesized peptide, which uses its superior binding abilities to eliminate the unwanted Class II-associated invariant chain peptide (CLIP) that is displayed on specific B cells that leads to chronic inflammation. The company also provides metabolic disruption technology (MDT) compounds impede tumor cells that sensitize cancer cells to treatment by disrupting the metabolic strategies those cells use to survive; and Hydroxychloroquine, a MDT compound that can be used in combination with other cancer drugs for treating drug-resistant cancers. In addition, it offers targeted peptide technology (TPT), a technology that eliminates the subpopulation of pro-inflammatory immune cells and presents a possible treatment for autoimmune and infectious diseases. VG Life Sciences Inc. was formerly known as Viral Genetics Inc. and changed its name to VG Life Sciences Inc. in November 2012. The company was founded in 1995 and is based in Santa Barbara, California. VG Life Sciences Inc. operates as a subsidiary of Feelux Co., Ltd.

Corporate Governance

VG Life Sciences Inc.s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.